Joel Greenblatt Alnylam Pharmaceuticals, Inc. Transaction History
Gotham Asset Management, LLC
- $7.56 Billion
- Q2 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 13,237 shares of ALNY stock, worth $3.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,237
Previous 2,047
546.65%
Holding current value
$3.6 Million
Previous $305,000
954.43%
% of portfolio
0.04%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ALNY
# of Institutions
639Shares Held
108MCall Options Held
2.11MPut Options Held
2.04M-
Capital World Investors Los Angeles, CA15MShares$4.08 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.4 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.6 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.69 Billion0.28% of portfolio
-
Baillie Gifford & CO4.89MShares$1.33 Billion1.03% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...